Hedge funds cut NFLX, keep big bets on MSFT, AMZN, add NVDA
In a challenging market environment, IPG Photonics (NASDAQ:IPGP) Corporation’s stock has touched a 52-week low, dipping to $56.67. With a current market capitalization of $2.43 billion, InvestingPro analysis indicates the company is slightly undervalued at current levels. The company, known for its leading-edge developments in high-performance fiber lasers and amplifiers, has faced significant headwinds over the past year, reflected in a substantial revenue decline of 24.1%. Despite these challenges, InvestingPro data reveals the company maintains strong financial health with more cash than debt and a robust current ratio of 6.98. This downturn marks a notable shift for investors and the company alike, as they navigate through the pressures affecting the broader tech sector and the specific demands of the photonics industry. Get access to 10+ additional exclusive ProTips and comprehensive analysis with a Pro Research Report, available on InvestingPro.
In other recent news, IPG Photonics reported a 22% year-over-year decline in fourth-quarter 2024 revenue, totaling $234 million, primarily due to decreased demand in the general industrial and e-mobility sectors. The company also posted earnings per share (EPS) of $0.18, marking an 80% drop from the previous year, affected by unusual tax items. Looking ahead, IPG Photonics forecasts first-quarter 2025 revenue between $210 million and $240 million, slightly below consensus estimates, with anticipated EPS ranging from $0.05 to $0.35, a potential 90% to 33% year-over-year decline. Analysts at Stifel have lowered the company’s price target to $85 but maintained a Buy rating, citing the company’s strong technology portfolio and balance sheet as competitive advantages. Meanwhile, Citi analysts reiterated a Sell rating with a $62 price target, highlighting the company’s high operating expenses and tax rates. Despite these challenges, IPG Photonics plans to increase research and development investments to explore new market opportunities in sectors like medical devices and micro-machining. Management is focusing on execution and cost management, although the benefits of these strategic efforts are not expected to materialize until 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.